| Typicality: | 0.225 |
| Saliency: | 0.148 |
| into the fourth quarter of 2019 | 7 | temporal |
| cash → fund → our ongoing trials | 4 |
| cash → fund → ongoing trials | 3 |
| negative | neutral | positive |
| 0.003 | 0.298 | 0.699 |
| Raw frequency | 7 |
| Normalized frequency | 0.148 |
| Modifier score | 0.500 |
| Perplexity | 420.642 |